Proton Rahman Selected Research

Phosphatidylcholines (Phosphatidylcholine)

1/2023	Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patients.
1/2020	Metabolomics Signature for Non-Responders to Total Joint Replacement Surgery in Primary Osteoarthritis Patients: The Newfoundland Osteoarthritis Study.
11/2019	Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.
1/2019	Activation of The Phosphatidylcholine to Lysophosphatidylcholine Pathway Is Associated with Osteoarthritis Knee Cartilage Volume Loss Over Time.
1/2016	Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Proton Rahman Research Topics

Disease

67	Psoriatic Arthritis 03/2024 - 09/2005
43	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 01/2007
25	Ankylosing Spondylitis 04/2024 - 10/2005
14	Pain (Aches) 04/2024 - 03/2016
13	Axial Spondyloarthritis 02/2024 - 04/2016
11	Infections 10/2023 - 06/2009
11	Rheumatoid Arthritis 01/2023 - 01/2007
9	Inflammation (Inflammations) 04/2024 - 12/2003
9	Arthritis (Polyarthritis) 02/2024 - 12/2003
7	Fatigue 03/2024 - 07/2011
5	Osteoarthritis 01/2022 - 01/2020
5	Knee Osteoarthritis 01/2021 - 02/2006
5	Necrosis 12/2020 - 06/2014
4	Crohn Disease (Crohn's Disease) 10/2023 - 01/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 04/2011
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2012 - 09/2003
2	Chronic Disease (Chronic Diseases) 03/2024 - 01/2021
2	Non-Radiographic Axial Spondyloarthritis 02/2024 - 03/2021
2	Opportunistic Infections (Opportunistic Infection) 10/2023 - 12/2021
2	Neoplasms (Cancer) 10/2023 - 12/2021
2	Tuberculosis (Tuberculoses) 10/2023 - 12/2021
2	Joint Diseases (Joint Disease) 10/2023 - 07/2008
2	Injection Site Reaction 12/2021 - 01/2020
2	Musculoskeletal Pain 01/2021 - 01/2021
2	Disease Progression 12/2018 - 05/2007
2	Back Pain (Backache) 04/2016 - 10/2008
1	Migraine Disorders (Migraine) 02/2024
1	Diarrhea 02/2024
1	Nausea 02/2024
1	Ulcerative Colitis 10/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Hypertrophy 04/2022
1	Insulin Resistance 04/2022

Drug/Important Bio-Agent (IBA)

21	guselkumabIBA 03/2024 - 01/2020
14	C-Reactive ProteinIBA 04/2024 - 10/2008
13	ixekizumabIBA 04/2024 - 10/2017
13	Monoclonal AntibodiesIBA 07/2023 - 08/2013
12	Interleukin-23 (Interleukin 23)IBA 01/2024 - 04/2008
12	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 08/2013
10	Interleukin-17 (Interleukin 17)IBA 07/2023 - 09/2015
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 10/2008
9	secukinumabIBA 01/2021 - 09/2015
8	ametantrone (HAQ)IBA 03/2024 - 07/2011
7	InterleukinsIBA 01/2024 - 08/2010
7	Infliximab (Remicade)FDA Link 01/2023 - 08/2010
7	golimumab FDA Link 01/2023 - 08/2017
6	CytokinesIBA 01/2023 - 01/2007
5	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2023 - 01/2016
5	Interleukin-12 (IL 12)IBA 01/2023 - 02/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2005
5	HLA-B Antigens (HLA-B)IBA 12/2018 - 07/2013
5	NF-kappa B (NF-kB)IBA 05/2012 - 09/2005
4	Adalimumab (Humira)FDA Link 04/2024 - 12/2007
4	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 03/2012
4	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 07/2010
4	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021 - 01/2016
4	Interleukin-1 (Interleukin 1)IBA 06/2009 - 10/2005
3	InterferonsIBA 10/2023 - 01/2017
3	EnzymesIBA 08/2013 - 07/2010
2	Immunoglobulin A (IgA)IBA 01/2024 - 01/2022
2	SphingomyelinsIBA 01/2023 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2015
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2023 - 07/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 09/2003
2	Interleukin-23 Subunit p19IBA 12/2022 - 01/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 04/2022 - 01/2021
2	Antirheumatic Agents (DMARD)IBA 04/2022 - 06/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2017
2	Genetic Markers (Genetic Marker)IBA 12/2018 - 10/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 04/2015
2	P-2 (P 2)IBA 01/2017 - 11/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 10/2013
2	Interleukin-13IBA 06/2015 - 09/2011
2	Peptides (Polypeptides)IBA 07/2013 - 07/2011
2	AminopeptidasesIBA 07/2013 - 07/2011
2	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 08/2011 - 04/2011
2	Toll-Like Receptor 4IBA 05/2008 - 02/2007
2	protein kinase C etaIBA 05/2007 - 12/2003
1	apremilastIBA 02/2024
1	omega-Chloroacetophenone (Mace)IBA 10/2023
1	Small Cytoplasmic RNAIBA 10/2023
1	Biosimilar PharmaceuticalsIBA 07/2023
1	risankizumabIBA 01/2023
1	HLA-B13 AntigenIBA 01/2023
1	HLA-B57 antigenIBA 01/2023
1	HLA-B38 AntigenIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2022
1	Amino Acids FDA Link 04/2022
1	Branched-Chain Amino AcidsIBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 04/2022
1	Insulin (Novolin)FDA Link 04/2022

Therapy/Procedure

17	Therapeutics 03/2024 - 09/2003
5	Biological Therapy 12/2022 - 11/2011
3	Replacement Arthroplasty 01/2021 - 01/2020
1	Subcutaneous Injections 10/2023
1	Precision Medicine 10/2023
1	Retreatment 02/2023
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2023
1	Diet Therapy (Therapy, Diet) 04/2022